Cytalux (pafolacianince), a drug that binds to ovarian cancer tissue and glows when exposed to fluorescent light, has been approved by the U.S. Food and Drug Administration (FDA) to help surgeons detect ovarian tumors during surgical procedures in patients.
source https://www.foxnews.com/health/fda-approves-glowing-tumor-drug-to-help-surgeons-identify-ovarian-cancer-cells
source https://www.foxnews.com/health/fda-approves-glowing-tumor-drug-to-help-surgeons-identify-ovarian-cancer-cells
تعليقات
إرسال تعليق